Skip to content

ORASURE TECHNOLOGIES INC

OSUR · XNAS

CIK 1116463fmd_08P60T79H0HG9EWRN01GKV86TCManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues128167182155172234387405186115
Cost of revenue406868607011623923410667
Gross profit8899114951021181481727948
Research and development10131620313436342643
Selling, general and administrative585869677795117957774
Total operating expenses68598576107128171139108120
Operating income20402819(5)(10)(22)33(28)(72)
Interest expense––––––––––
Interest and investment income––––––26118
Other non-operating income (expense)013321318(0)0
Income before taxes20413221(4)(9)(16)56(16)(65)
Income tax expense11011511141322
Net income from continuing operations20312017(15)(23)(17)54(18)(66)
Net income20312017(15)(23)(17)54(20)(69)
ORASURE TECHNOLOGIES INC (OSUR) financial statements · FinancialMD